These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 26351031)

  • 1. Galectin-3 Participates in Cardiovascular Remodeling Associated With Obesity.
    Martínez-Martínez E; López-Ándres N; Jurado-López R; Rousseau E; Bartolomé MV; Fernández-Celis A; Rossignol P; Islas F; Antequera A; Prieto S; Luaces M; Cachofeiro V
    Hypertension; 2015 Nov; 66(5):961-9. PubMed ID: 26351031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-3 Blockade Reduces Renal Fibrosis in Two Normotensive Experimental Models of Renal Damage.
    Martinez-Martinez E; Ibarrola J; Calvier L; Fernandez-Celis A; Leroy C; Cachofeiro V; Rossignol P; Lopez-Andres N
    PLoS One; 2016; 11(11):e0166272. PubMed ID: 27829066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice.
    Vergaro G; Prud'homme M; Fazal L; Merval R; Passino C; Emdin M; Samuel JL; Cohen Solal A; Delcayre C
    Hypertension; 2016 Mar; 67(3):606-12. PubMed ID: 26781273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galectin-3 blockade inhibits cardiac inflammation and fibrosis in experimental hyperaldosteronism and hypertension.
    Martínez-Martínez E; Calvier L; Fernández-Celis A; Rousseau E; Jurado-López R; Rossoni LV; Jaisser F; Zannad F; Rossignol P; Cachofeiro V; López-Andrés N
    Hypertension; 2015 Oct; 66(4):767-75. PubMed ID: 26238446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galectin-3 mediates the pulmonary arterial hypertension-induced right ventricular remodeling through interacting with NADPH oxidase 4.
    He J; Li X; Luo H; Li T; Zhao L; Qi Q; Liu Y; Yu Z
    J Am Soc Hypertens; 2017 May; 11(5):275-289.e2. PubMed ID: 28431936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Galectin-3 inhibition prevents adipose tissue remodelling in obesity.
    Martínez-Martínez E; Calvier L; Rossignol P; Rousseau E; Fernández-Celis A; Jurado-López R; Laville M; Cachofeiro V; López-Andrés N
    Int J Obes (Lond); 2016 Jun; 40(6):1034-8. PubMed ID: 26853916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of galectin-3 ameliorates the consequences of cardiac lipotoxicity in a rat model of diet-induced obesity.
    Marín-Royo G; Gallardo I; Martínez-Martínez E; Gutiérrez B; Jurado-López R; López-Andrés N; Gutiérrez-Tenorio J; Rial E; Bartolomé MAV; Nieto ML; Cachofeiro V
    Dis Model Mech; 2018 Feb; 11(2):. PubMed ID: 29361517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial Effects of Galectin-3 Blockade in Vascular and Aortic Valve Alterations in an Experimental Pressure Overload Model.
    Ibarrola J; Martínez-Martínez E; Sádaba JR; Arrieta V; García-Peña A; Álvarez V; Fernández-Celis A; Gainza A; Rossignol P; Cachofeiro Ramos V; López-Andrés N
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calorie restriction attenuates cardiac remodeling and diastolic dysfunction in a rat model of metabolic syndrome.
    Takatsu M; Nakashima C; Takahashi K; Murase T; Hattori T; Ito H; Murohara T; Nagata K
    Hypertension; 2013 Nov; 62(5):957-65. PubMed ID: 24041949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for galectin-3 in the development of early molecular alterations in short-term aortic stenosis.
    Arrieta V; Martinez-Martinez E; Ibarrola J; Alvarez V; Sádaba R; Garcia-Peña A; Fernández-Celis A; Cachofeiro V; Rossignol P; López-Andrés N
    Clin Sci (Lond); 2017 May; 131(10):935-949. PubMed ID: 28360193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3 pharmacological inhibition attenuates early renal damage in spontaneously hypertensive rats.
    Martínez-Martínez E; Ibarrola J; Fernández-Celis A; Calvier L; Leroy C; Cachofeiro V; Rossignol P; López-Andrés N
    J Hypertens; 2018 Feb; 36(2):368-376. PubMed ID: 28858976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smad3 Signaling Promotes Fibrosis While Preserving Cardiac and Aortic Geometry in Obese Diabetic Mice.
    Biernacka A; Cavalera M; Wang J; Russo I; Shinde A; Kong P; Gonzalez-Quesada C; Rai V; Dobaczewski M; Lee DW; Wang XF; Frangogiannis NG
    Circ Heart Fail; 2015 Jul; 8(4):788-98. PubMed ID: 25985794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis.
    Yu L; Ruifrok WP; Meissner M; Bos EM; van Goor H; Sanjabi B; van der Harst P; Pitt B; Goldstein IJ; Koerts JA; van Veldhuisen DJ; Bank RA; van Gilst WH; Silljé HH; de Boer RA
    Circ Heart Fail; 2013 Jan; 6(1):107-17. PubMed ID: 23230309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulated galectin-3 is not a critical disease mediator of cardiomyopathy induced by β
    Nguyen MN; Su Y; Kiriazis H; Yang Y; Gao XM; McMullen JR; Dart AM; Du XJ
    Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1169-H1178. PubMed ID: 29424570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac remodeling and diastolic dysfunction in DahlS.Z-Lepr(fa)/Lepr(fa) rats: a new animal model of metabolic syndrome.
    Murase T; Hattori T; Ohtake M; Abe M; Amakusa Y; Takatsu M; Murohara T; Nagata K
    Hypertens Res; 2012 Feb; 35(2):186-93. PubMed ID: 21918527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-3 mediates aldosterone-induced vascular fibrosis.
    Calvier L; Miana M; Reboul P; Cachofeiro V; Martinez-Martinez E; de Boer RA; Poirier F; Lacolley P; Zannad F; Rossignol P; López-Andrés N
    Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):67-75. PubMed ID: 23117656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Obesity on Cardiovascular Hemodynamics, Cardiac Morphology, and Ventricular Function.
    Alpert MA; Omran J; Bostick BP
    Curr Obes Rep; 2016 Dec; 5(4):424-434. PubMed ID: 27744513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition.
    Ibarrola J; Matilla L; Martínez-Martínez E; Gueret A; Fernández-Celis A; Henry JP; Nicol L; Jaisser F; Mulder P; Ouvrard-Pascaud A; López-Andrés N
    Sci Rep; 2019 Jul; 9(1):9607. PubMed ID: 31270370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exaggerated blood pressure variability superimposed on hypertension aggravates cardiac remodeling in rats via angiotensin II system-mediated chronic inflammation.
    Kudo H; Kai H; Kajimoto H; Koga M; Takayama N; Mori T; Ikeda A; Yasuoka S; Anegawa T; Mifune H; Kato S; Hirooka Y; Imaizumi T
    Hypertension; 2009 Oct; 54(4):832-8. PubMed ID: 19704105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries.
    Calvier L; Martinez-Martinez E; Miana M; Cachofeiro V; Rousseau E; Sádaba JR; Zannad F; Rossignol P; López-Andrés N
    JACC Heart Fail; 2015 Jan; 3(1):59-67. PubMed ID: 25458174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.